MedPath

Oxeladin

Generic Name
Oxeladin
Drug Type
Small Molecule
Chemical Formula
C20H33NO3
CAS Number
468-61-1
Unique Ingredient Identifier
SNC1080T5Y

Overview

Withdrawn from the Canadian, US, and UK markets in 1976 due to carcinogenicity.

Background

Withdrawn from the Canadian, US, and UK markets in 1976 due to carcinogenicity.

Indication

用于因呼吸道感染如咽炎、喉炎、支气管炎等引起的咳嗽;各种气道损伤或胸膜受刺激而引起的咳嗽,如吸烟者的痉挛性咳嗽以及肿瘤、支气管扩张等所致的咳嗽。

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.
© Copyright 2025. All Rights Reserved by MedPath